SIRT3‐Mediated CypD‐K166 Deacetylation Alleviates Neuropathic Pain by Improving Mitochondrial Dysfunction and Inhibiting Oxidative Stress
Open Access
- 1 September 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 4722647
Abstract
Numerous studies have shown that mitochondrial dysfunction manifested by increased mitochondrial permeability transition pore (mPTP) opening and reactive oxygen species (ROS) level, and decreased mitochondrial membrane potential (MMP) plays an important role in the development of neuropathic pain. Sirtuin3 (SIRT3), a nicotinamide adenine dinucleotide (NAD+)‐dependent histone deacetylase, has been shown to inhibit mitochondrial oxidative stress. However, the role of SIRT3 in neuropathic pain is unclear. In this study, we found that the protein and mRNA levels of SIRT3 were significantly downregulated in the spinal cords of spared nerve injury‐ (SNI‐) induced neuropathic pain mice, while overexpression of spinal SIRT3 reversed SNI‐induced pain hypersensitivity. Further study showed that SIRT3 overexpression reduced the acetylation level of lysine 166 (K166) on cyclophilin D (CypD), the regulatory component of the mPTP, inhibited the mPTP opening, decreased ROS and malondialdehyde (MDA) levels, and increased MMP and manganese superoxide dismutase (MnSOD) in SNI mice. Point mutation of K166 to arginine on CypD (CypD‐K166R) abrogated SNI‐induced mitochondrial dysfunction and neuropathic pain in mice. Moreover, inhibiting mPTP opening by cyclosporin A (CsA) improved mitochondrial function and neuropathic pain in SNI mice. Together, these data show that SIRT3 is necessary to prevent neuropathic pain by deacetylating CypD‐K166 and further improving mitochondrial dysfunction. This study may shed light on a potential drug target for the treatment of neuropathic pain.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20191464)
- National Natural Science Foundation of China (81971051, 82071232)
This publication has 57 references indexed in Scilit:
- The changes of mitochondrial cytochrome c and GABAergic neuron in neuropathic pain modelKorean Journal of Anesthesiology, 2012
- Epigenetic suppression of GAD65 expression mediates persistent painNature Medicine, 2011
- Sirt3, Mitochondrial ROS, Ageing, and CarcinogenesisInternational Journal of Molecular Sciences, 2011
- Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA releasePain, 2011
- Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationNature, 2010
- Antimycin A and lipopolysaccharide cause the leakage of superoxide radicals from rat liver mitochondriaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell deathNature, 2005
- Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathyPain, 2004
- Reactive Oxygen Species (Ros-Induced) Ros ReleaseJournal of Experimental Medicine, 2000